What’s Fueling Bruker Corp (BRKR) Stock’s -5.83% Loss Below Its 200-Day SMA?
Wolfe Research has recently reduced Bruker Corp (BRKR) stock to Peer Perform rating, as announced on September 30, 2024, according to Finviz. Earlier, on August 28, 2024, Wells Fargo had initiated the stock to Overweight, setting a price target of $78. Jefferies also resumed Buy rating with a price target of $85. Additionally, JP Morgan […]
Advantage Solutions Inc (ADV) Posted -4.66% Profit Margin Last Year—Can It Hold Up?
Canaccord Genuity has recently initiated Advantage Solutions Inc (ADV) stock to Buy rating, as announced on December 6, 2023, according to Finviz. Earlier, on May 11, 2023, Morgan Stanley had resumed the stock rating, setting a price target of $3. Deutsche Bank also initiated Hold rating with a price target of $7. Additionally, Goldman reduced […]
Celanese Corporation (CE) Reported a 11.04% Operating Margin Last Year—What’s the Real Story?
Piper Sandler has recently reduced Celanese Corporation (CE) stock to Neutral rating, as announced on September 5, 2024, according to Finviz. Earlier, on August 5, 2024, JP Morgan had raised the stock from a Underweight to Neutral, setting a price target of $130 for CE stock. JP Morgan also reduced Underweight rating with a price […]
What’s Driving Baxter International Inc (BAX) Stock’s -0.50% Plunge Over the Past Month?
Morgan Stanley has recently reduced Baxter International Inc (BAX) stock rating, as announced on July 15, 2024, according to Finviz. Earlier, on May 30, 2024, Goldman had initiated the stock to Neutral, setting a price target of $36. TD Cowen also reduced Hold rating with a price target of $40. Additionally, Morgan Stanley resumed their […]
Why Did Terns Pharmaceuticals Inc (TERN) Stock Tumble -2.46% to $8.34?
Mizuho has recently initiated Terns Pharmaceuticals Inc (TERN) stock to Buy rating, as announced on June 22, 2023, according to Finviz. Earlier, on June 7, 2023, Jefferies had initiated the stock to Buy, setting a price target of $18. ROTH MKM also initiated Buy rating with a price target of $23. Additionally, BMO Capital Markets […]
Analysts Predict a $10 Target for Diamondrock Hospitality Co (DRH) Stock—What Could Drive It There?
Compass Point has recently raised Diamondrock Hospitality Co (DRH) stock to Buy rating, as announced on August 5, 2024, according to Finviz. Earlier, on January 10, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $11. Wells Fargo also reduced Equal Weight rating with a price target of $9. Additionally, […]
What’s Behind the -2.47% Drop in First Solar Inc (FSLR) Stock? Find Out Now!
Truist has recently initiated First Solar Inc (FSLR) stock to Buy rating, as announced on September 26, 2024, according to Finviz. Earlier, on August 29, 2024, William Blair had initiated the stock to Mkt Perform. Clarksons Platou also initiated Buy rating with a price target of $270. Additionally, DZ Bank raised Buy rating on August […]
Needham Just Reiterated Viridian Therapeutics Inc (VRDN) Stock—What Does This Mean for Investors?
Needham has recently reiterated Viridian Therapeutics Inc (VRDN) stock to Buy rating, as announced on September 11, 2024, according to Finviz. Earlier, on June 11, 2024, Wolfe Research had initiated the stock to Outperform, setting a price target of $29. Goldman also initiated Buy rating with a price target of $23. Additionally, Ladenburg Thalmann reduced […]
How Does Zillow Group Inc Class C (Z) Stack Up Against Its Industry Peers?
Gordon Haskett has recently initiated Zillow Group Inc Class C (Z) stock to Hold rating, as announced on April 18, 2023, according to Finviz. Earlier, on February 3, 2022, Jefferies had resumed the stock to Buy, setting a price target of $75 for Z stock. Standpoint Research also reduced Hold rating. Additionally, Needham raised Buy […]
Humacyte Inc (HUMA) Stock: More Strategic Than Meets the Eye
H.C. Wainwright has recently initiated Humacyte Inc (HUMA) stock to Buy rating, as announced on December 11, 2023, according to Finviz. Earlier, on August 14, 2023, Piper Sandler had raised the stock from a Underweight to Neutral, setting a price target of $3.50 for HUMA stock. Cantor Fitzgerald also initiated Overweight rating with a price […]
